New injection aims to strengthen weakened bones
NCT ID NCT05509595
Summary
This study tested a drug called burosumab in people with fibrous dysplasia, a condition that causes weak, deformed bones and often low phosphate levels. Twelve participants aged 1 and older gave themselves burosumab injections at home once or twice a month for 48 weeks. Researchers checked if the drug could safely raise phosphate levels to a normal range and improve bone health, pain, and mobility.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROUS DYSPLASIA OF BONE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.